DAC NYSE Week ended 24 Jul 2026

Weekly Investor Report

Danaos Corporation · Industrials · Marine Shipping

Open interactive chart View report data
Latest close 140.2 USD
12.2% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 20.9% above the Trend Line and sits at 99.3% of its 52-week range. The latest completed week returned 12.2%, after a 14.8% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is inexpensive relative to peers. Options positioning is bullish with 51/100 conviction, while the latest news-sentiment score is 57/100. Near-term considerations: price is close to its 52-week high; earnings are due in 2d.

Setup score 76 out of 100
Latest Close 140.2 USD 24 Jul 2026
1W Return 12.2% latest completed week
4W Return 14.8% short-term follow-through
12W Return 17.9% quarterly tape
Trend Breadth 100.0% 52 of 52 weeks active
Volume Ratio 1.3x vs 13-week average
What is working
  • The trend backdrop is active with a 62-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Next-week expectancy is positive at 56.53% based on similar historical setup states.
What could go wrong
  • Activity pressure is negative, which weakens the current setup.
  • 4 reversal markers appear in the recent smart-money tape.
  • Recent volatility is running well above the one-year baseline.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 12.2% Latest completed week; four-week move 14.8%. Indicator stack 100/36 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 56.53% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Bullish 51/100 conviction; expected move 5.3%. News sentiment 57/100 54 relevant articles in the latest sentiment read. Event risk 2d Next report is scheduled for 03 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 20.9% above the Trend Line and sits at 99.3% of its 52-week range. The latest completed week returned 12.2%, after a 14.8% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.3x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.8412-week average 0.93

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure9/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.84Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers44 reversal markers

No recent accumulation markers. 4 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 14.8% over four weeks, 17.9% over 12 weeks, and 57.2% over one year. The current trend has remained active for 62 consecutive weeks.

Performance by holding period

1W12.2%
4W14.8%
12W17.9%
26W41.4%
52W57.2%
Active trend streak62 weeks
Active weeks in one year52
Trend breadth100.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.23Latest activity-pressure read.
Pressure change-128.1%Four-week change in activity pressure.
Leadership24.09Latest relative-leadership reading.
RS change110.9%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 100% Model confidence 96%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength99/100Blend of value, momentum, and quality. Underlying universe rank 2; rank 1 is best.
Value98/100Relative valuation strength. Underlying universe rank 3; rank 1 is best.
Quality84/100Profitability and accounting quality. Underlying universe rank 17; rank 1 is best.
Momentum86/100Medium-term price momentum. Underlying universe rank 15; rank 1 is best.
Growth71/100Revenue and earnings growth. Underlying universe rank 30; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework86/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
4.9x
Price divided by trailing earnings.
Price / sales
2.4x
Market value relative to trailing revenue.
EV / EBITDA
3.5x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
38.6%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
67.7%
Gross profit retained from each unit of revenue.
Operating margin
54.5%
Operating profit retained from revenue.
Free-cash-flow margin
100.0%
Free cash flow generated from revenue.
Return on invested capital
10.5%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
2.8%
Latest one-year revenue growth.
EPS growth
10.7%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-14.7%
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
1.9%
Cash dividends relative to market value.
Buyback yield
1.9%
Net share repurchases relative to market value.
Shareholder yield
3.8%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.2x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

DAC shows bullish options pressure with a 51/100 conviction score, put-call volume ratio of 0.11, expected move of 5.3%, and Sharemaestro trend signal active.

Conviction51/100
Expected move5.3%
Put/call volume0.11
Pressure91
Speculation28
Volatility42
Trend agreement11
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment57/100

Weighted news tone is neutral across 54 relevant articles.

19 positive · 32 neutral · 3 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings2dNext report is scheduled for 03 Aug 2026; event risk rises as the date approaches.
Options expected move5.3%Nearest-chain priced movement where available.
52-week drawdown-0.3%Distance below the 52-week high.
13-week volatility5.3%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2612 weeks finished lower.
Best week+12.4%Week of 8 May.
Worst week-6.8%Week of 6 Mar.
Latest week+12.2%Week of 24 Jul.

Shape of recent returns

Strong gains7
Modest gains7
Flat weeks0
Modest losses10
Sharp losses2
Recent vol5.3%13-week weekly-return volatility.
Base vol3.8%52-week weekly-return volatility.
Up/down split29/23Count of positive and negative weeks in the 52-week window.
Average skew3.5% / -2.3%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape74/100

Trend, activity pressure, participation, and risk combine to a 74/100 tape read.

 Indicator analysis75/100

Latest 12-week confirmation: trend 12/12, activity pressure 9/12, relative leadership 12/12.

Activity pressure 0.84; 4 reversal markers Next-Week ExpectancyPositive 56.53%

Next-week expectancy is positive with a 56.53% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors91/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 24; Small Cap Core rank 6 SVQF86/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 146.5 of 1013 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options50/100

DAC shows bullish options pressure with a 51/100 conviction score, put-call volume ratio of 0.11, expected move of 5.3%, and Sharemaestro trend signal active.

Bullish · Call-side pressure · Expected move 5.3% Sentiment57/100

Weighted news tone is neutral across 54 relevant articles.

Danaos Corp (DAC) Financial Health: Profitability & Balance Sheet Analysis Insiders50/100

No recent insider transaction evidence is stored.

 Earnings2d

Next report is scheduled for 03 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 2026140.2 USD12.2%116.0 USD83.88 USD-0.2324.09581.2KOn
17 Jul 2026125.0 USD-2.0%114.4 USD83.39 USD-0.4410.65536.6KOn
10 Jul 2026127.5 USD5.0%113.3 USD82.97 USD-0.2211.52442.4KOn
3 Jul 2026121.5 USD-0.6%112.1 USD82.53 USD0.288.08333.9KOn
26 Jun 2026122.2 USD-2.3%111.3 USD82.14 USD0.8111.42538.7KOn
19 Jun 2026125.1 USD-4.7%110.4 USD81.74 USD1.1111.77303.1KOn
12 Jun 2026131.3 USD1.6%109.3 USD81.32 USD1.4718.77293.7KOn
5 Jun 2026129.2 USD3.2%108.0 USD80.85 USD1.5517.98436.2KOn
29 May 2026125.2 USD-3.6%106.7 USD80.39 USD1.8011.99410.9KOn
22 May 2026129.9 USD0.5%105.5 USD79.94 USD1.8618.28501.9KOn
15 May 2026129.3 USD-3.3%104.0 USD79.43 USD1.6119.22508.0KOn
8 May 2026133.7 USD12.4%102.5 USD78.95 USD1.5024.10674.6KOn
1 May 2026118.9 USD2.0%100.8 USD78.41 USD1.1913.58401.2KOn
24 Apr 2026116.6 USD-0.4%99.70 USD77.97 USD1.1112.72213.6KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.